A batch can be fully packed, fully tested, correctly labelled and sitting on a pallet in a licensed warehouse, and still be legally worthless. Until a Qualified Person has certified it, it is not a medicine that can be placed on the market. It is stock. QP release is where every other strand of pharma … Continued

Building your own licensed warehouse is a large capital decision taken before you have shipped a pallet. Racking, qualified temperature zones, monitoring, a controlled drug vault, a warehouse management system, a Responsible Person, an MHRA inspection, a WDA(H). Then you carry all of it whether the volume arrives or not. That arithmetic is why most … Continued

A pharmacy orders four packs. A hospital orders a pallet. A clinical site orders two chilled cartons that must arrive before nine tomorrow morning. All three hit the same warehouse, the same stock and the same team, and all three must leave with a complete batch and expiry record attached. That is the difference between … Continued

If you own a medicinal product supply chain, GDP is the standard your pharma warehousing is held to from the moment a batch is certified until it reaches your customer. It is also the standard the MHRA will inspect that warehouse against, whether it is yours or somebody else’s. The document itself is short. The … Continued

Most companies discover the difficulty of controlled drug storage late, usually when a product moves from clinical supply into commercial volumes and somebody asks where the stock will sit. The answer is not a lockable cupboard in the corner of a warehouse. Controlled drugs sit under a separate legal regime from the rest of your … Continued

A cold room alarm fires at 02:40 on a Sunday. Nobody is on site. By the time somebody opens the notification on Monday morning, the stock inside has spent a day and a half at a temperature nobody can now reconstruct. Pharmaceutical cold storage is rarely lost to refrigeration engineering. It is lost in the … Continued

“Cold chain” is used loosely to mean anything that is not room temperature. That vagueness causes real problems in tenders, because a site qualified for +2°C to +8°C and a site qualified for -80°C run different equipment, different alarm strategies and different failure plans. Temperature controlled pharmaceutical storage covers a series of defined bands, each … Continued

Most tender documents for pharmaceutical distribution describe the destination and the volume. Very few describe the twenty or so controlled handoffs that sit between a batch leaving a manufacturing site and a pack reaching a pharmacy, hospital or patient. That gap is where problems come from. A pharmaceutical logistics company is not simply moving boxes … Continued

A pallet of tablets and a pallet of tinned food take up the same floor space. Almost nothing else about how they are stored is the same. Pharmaceutical warehousing is the licensed, controlled storage of medicinal products, active substances and healthcare goods under conditions that preserve their quality, safety and traceability from goods-in through to … Continued

GMP and GDP get used almost interchangeably in supplier conversations, and that causes real problems. They are different legal regimes, under different authorisations, inspected differently, with a precise boundary between them. Choosing a pharmaceutical packaging company without understanding that boundary is how organisations end up with a batch that is packed but stranded, or stock … Continued

An auditor looking at tablet blister packaging asks a narrow set of questions. Can you show the line was qualified for this material and this format? What are the critical process parameters, how were the ranges established, and what happens when one drifts? How do you know every pocket contained exactly one tablet? How do … Continued

Two decisions determine whether a blister project runs smoothly: the material specification and the packer you give it to. Most of the difficulty buyers experience with medication blister packaging traces back to one of those two being settled late, or settled on price alone. Material choice is a stability question before it is a cost … Continued